Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Do you know, that buy dildos is easy and safety?
Popular Articles

EpiCept Initiates Post-Approval Clinical Study With Ceplene(R)
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced the start of a post-approval clinical study with Ceplene® (histamine dihydrochloride) following Ethics Committee and Competent Authority approvals in Sweden, Belgium, and France. This study will fulfill the post approval commitments requested by the European Medicines Evaluation Agency (EMEA) in granting marketing authorization. Ceplene® is indicated for remission maintenance in adult patients with Acute Myeloid Leukemia (AML) in first remission. Ceplene®is to be administered in conjunction with low-dose interleukin-2 (IL-2).
drugs without prescription
New Pre-Clinical Data On OmniGuide's BeamPath NEURO(TM) Demonstrates Precise Cutting In Brain Tissue
OmniGuide, Inc., the developer of the first and only flexible CO2 laser fiber based on breakthrough photonic bandgap technology, announced the results of a pre-clinical study comparing the Company"s fiber scalpels to conventional incision methods in neurosurgery. In the study, surgeons from the Barrow Neurological Institute reported that careful studies of incisions produced in live brain tissue with fiber delivered CO2 laser radiation produced precise cuts while minimally effecting adjacent brain tissue when compared with a widely used reference technique. The study, led by Drs. Mark Preul, Robert W. Ryan, and Robert Spetzler of the Neurosurgery Research Laboratory, Barrow Neurological Institute, in Phoenix, Arizona, was presented at the annual conference of the American Academy of Neurological Surgeons in San Diego, California.
News of the day
New York Times Examines Debate Surrounding Use Of Experimental Treatments In Terminally Ill Patients
Some patient advocates are lobbying to legalize "compassionate use" of experimental drugs for people with terminal illnesses who have exhausted other treatments, prompting a debate about how and when to provide such patients with treatments that could prolong their lives, the New York Times reports. Most insurers do not cover unproven treatments, and physicians have concerns that using experimental treatment could give patients false hope and cause unnecessary pain. Drugmakers are concerned that if there are unfavorable outcomes from providing patients with an unproven treatment, it could hurt the drug"s chances of receiving FDA approval. At the same time, FDA does not want to grant drugs and their makers the opportunity to skip clinical trials. Currently, patients must individually apply to receive treatments through compassionate use (Harmon, New York Times, 5/17).
Sexual Health

London Health Service Begins Offering Rapid HIV Tests

Barts and the London NHS Trust has become the first National Health Service provider in the United Kingdom to offer rapid, oral HIV tests, BBC News reports. Officials hope that the service will increase the number of people who seek testing because requirements of giving blood and waiting for test results are eliminated with the rapid tests. Barts will offer the rapid, oral tests in non-health care settings such as outreach centers. In addition, sexual health workers hope to be able to offer the test in night clubs in the future. About 200 people in Barts clinics have received rapid tests since March, and officials hope to test 250 people monthly. Merle Symonds, the sexual health adviser at the trust, said the message that HIV is a treatable disease has not "filtered through and stigma does remain around HIV, even if it is waning." Lisa Power of the Terrence Higgins Trust -- an HIV/AIDS organization that also offers rapid, oral tests -- said that a major problem surrounding HIV/AIDS in the United Kingdom is that many people are not aware of their status. She added, "Anything we can do to increase the take-up of testing is welcome, and we think what Barts is doing is fantastic."According to BBC News, the United Kingdom has the largest number of people living with HIV in Western Europe, with men who have sex with men accounting for 41% of new cases. BBC News reports that approximately one-third of HIV-positive people in the country are not aware of their status (BBC News, 5/20). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009